GlassScriptPhysician profile
Amy M Burton
NPI 1154544054
$130,379.75
in general payments reported to CMS, 2019-2025
43 companies · $33K in 2025
The $33K reported for 2025 was more than what 95% of Pediatric Endocrinology providers received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $6,764 · 2021: $6,897 · 2022: $9,106 · 2023: $13K · 2024: $46K · 2025: $33K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $74K · Food and Beverage: $9,898 · Consulting Fee: $4,480 · Travel and Lodging: $3,807 · Education: $12.39.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $73,657.44 |
| Food and Beverage | $9,897.86 |
| Consulting Fee | $4,480.00 |
| Travel and Lodging | $3,806.78 |
| Education | $12.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $70,012.22 | 2023-2025 | |
| Alexion Pharmaceuticals, INC. | $34,554.97 | 2019-2025 | Strensiq |
| Abbvie INC. | $9,830.91 | 2019-2025 | Lupron Depot, Synthroid |
| Insulet Corporation | $2,160.55 | 2019-2024 | Omnipod |
| Pfizer INC. | $1,834.45 | 2019-2025 | |
| Novo Nordisk INC | $1,625.97 | 2019-2025 | Sogroya, Norditropin, Wegovy |
| Tandem Diabetes Care, INC. | $1,141.39 | 2019-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Ascendis Pharma Endocrinology INC | $1,013.24 | 2022-2025 | Skytrofa |
| Tolmar Pharmaceuticals, INC. | $883.76 | 2020-2022 | |
| Xeris Pharmaceuticals, INC. | $842.62 | 2020-2025 | Gvoke Hypopen |
| Embecta Corp. | $827.58 | 2023-2024 | Bd Nano 2nd Gen Pen Needle |
| Tolmar, INC. | $623.97 | 2023-2025 | Fensolvi |
| Neurocrine Biosciences, INC. | $601.47 | 2024-2025 | Crenessity |
| Endo Pharmaceuticals INC. | $507.01 | 2019-2023 | Supprelin |
| Medtronic, INC. | $368.64 | 2021-2025 | Minimed 780g, Inpen Smart Insulin Delivery System |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arbor Pharmaceuticals, INC. | $315.23 | 2019-2022 | |
| Amneal Pharmaceuticals LLC | $310.80 | 2019-2024 | Unithroid |
| Lilly USA, LLC | $288.41 | 2019-2023 | Baqsimi |
| Dexcom, INC. | $280.49 | 2019-2025 | Dexcom G6 Transmitter |
| Azurity Pharmaceuticals, INC. | $238.93 | 2023-2025 | Triptodur, Triptodur |
| Zealand Pharma US, INC. | $235.29 | 2021-2022 | |
| Eton Pharmaceuticals, INC. | $227.45 | 2022-2025 | Alkindi, Khindivi, Increlex |
| Ultragenyx Pharmaceutical INC. | $219.64 | 2019-2022 | |
| Sequel Med Tech, LLC | $193.04 | 2025 | Twiist |
| Ipsen Biopharmaceuticals, INC | $191.32 | 2019-2022 | |
| Sandoz INC. | $150.89 | 2019-2025 | Omnitrope |
| Soleno Therapeutics, INC. | $133.95 | 2025 | Vykat Xr |
| Rhythm Pharmaceuticals, INC. | $118.80 | 2021-2022 | |
| Amphastar Pharmaceuticals, INC. | $97.36 | 2023-2025 | Baqsimi |
| Endo USA, INC. | $88.65 | 2024-2025 | Supprelin |
| Ibsa Pharma INC. | $57.20 | 2019-2023 | Tirosint, Licart |
| Beta Bionics, INC. | $51.35 | 2023-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Stryker Corporation | $50.00 | 2022 | |
| Ferring Pharmaceuticals INC. | $45.90 | 2019-2020 | |
| Abbott Laboratories | $41.29 | 2020-2024 | Freestyle Libre 3 |
| Kyowa Kirin, INC. | $40.69 | 2023-2024 | Crysvita |
| Lifescan, INC. | $38.46 | 2020-2022 | |
| Medtronic Minimed, INC. | $36.17 | 2019-2020 | |
| Chiesi USA, INC. | $23.42 | 2024 | Myalept |
| Companion Medical, INC. | $22.20 | 2019 | |
| Amryt Pharma Holdings LTD | $21.81 | 2023 | Myalept |
| Antares Pharma, INC. | $17.37 | 2025 | Xyosted |
| Biomarin Pharmaceutical INC. | $14.89 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Burton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.